|
|
|
|
|
|
|
M T Wed Th F |
|
9 September, 2026 |
|
|
|
|
|
|
|
|
|
|
|
|
This year’s Lasker Awards were announced today and among the three winners were the scientists who revealed the connection between narcolepsy and the peptide orexin. Masashi Yanagisawa and Emmanual Mignot talk with Lei Lei Wu about the quarter-century journey between basic discovery and successful treatment. |
|
|
|
Karen Weintraub |
Deputy Editor, Endpoints News
|
|
|
|
 |
|
Lasker Award winners Masashi Yanagisawa and Emmanuel Mignot |
|
|
|
by Lei Lei Wu
|
The path to understanding a common sleep disorder started with lab banter and traveled through mice, dogs and more recently, the flu virus. Now, the... | |
|
|
|
|
|
|
by Max Bayer
|
The business of advancing shelved pharma assets continues to reap benefits, this time for Beeline Medicines and a lupus candidate provided by Bristol Myers Squibb. The... | |
|
|
|
|
|
|
by Kyle LaHucik
|
After tinkering with the biology of the broadly appealing anti-inflammatory NLRP3 pathway, NodThera is now plotting its pivotal trial plans for 2027. The decade-old biotech... | |
|
|
|
 |
|
|
|
by ENDPOINTS |
Plus news about Luma, Inno Medicine, Schrödinger, Assembly Biosciences, Gilead, Leyden Labs, Navion, Ridge Bio, and Opus Genetics. 📊 Compass Pathways touts one-year data for... | |
|
|
|
|
|
|
by Kyle LaHucik
|
Kura Oncology, the maker of the menin inhibitor Komzifti, is spinning out its diabetes R&D to a new company that has attracted the attention... | |
|
|
|
|
|
|
|
